Author
Listed:
- William F. Porto
(Pós-Graduação em Ciências Genômicas e Biotecnologia Universidade Católica de Brasília
S-Inova Biotech, Pós-graduação em Biotecnologia, Universidade Católica Dom Bosco
Porto Reports)
- Luz Irazazabal
(Pós-Graduação em Ciências Genômicas e Biotecnologia Universidade Católica de Brasília
University of Brasília)
- Eliane S. F. Alves
(University of Brasília)
- Suzana M. Ribeiro
(S-Inova Biotech, Pós-graduação em Biotecnologia, Universidade Católica Dom Bosco)
- Carolina O. Matos
(Universidade Federal de Goiás)
- Állan S. Pires
(Pós-Graduação em Ciências Genômicas e Biotecnologia Universidade Católica de Brasília)
- Isabel C. M. Fensterseifer
(Pós-Graduação em Ciências Genômicas e Biotecnologia Universidade Católica de Brasília
University of Brasília)
- Vivian J. Miranda
(Pós-Graduação em Ciências Genômicas e Biotecnologia Universidade Católica de Brasília)
- Evan F. Haney
(University of British Columbia)
- Vincent Humblot
(Laboratoire de Réactivité de Surface (LRS))
- Marcelo D. T. Torres
(Massachusetts Institute of Technology
Broad Institute of MIT and Harvard
Universidade Federal do ABC)
- Robert E. W. Hancock
(University of British Columbia)
- Luciano M. Liao
(Universidade Federal de Goiás)
- Ali Ladram
(Institut de Biologie Paris-Seine (IBPS), Biogenèse des Signaux Peptidiques (BIOSIPE))
- Timothy K. Lu
(Massachusetts Institute of Technology
Broad Institute of MIT and Harvard)
- Cesar de la Fuente-Nunez
(Massachusetts Institute of Technology
Broad Institute of MIT and Harvard)
- Octavio L. Franco
(Pós-Graduação em Ciências Genômicas e Biotecnologia Universidade Católica de Brasília
S-Inova Biotech, Pós-graduação em Biotecnologia, Universidade Católica Dom Bosco
University of Brasília)
Abstract
Plants are extensively used in traditional medicine, and several plant antimicrobial peptides have been described as potential alternatives to conventional antibiotics. However, after more than four decades of research no plant antimicrobial peptide is currently used for treating bacterial infections, due to their length, post-translational modifications or high dose requirement for a therapeutic effect . Here we report the design of antimicrobial peptides derived from a guava glycine-rich peptide using a genetic algorithm. This approach yields guavanin peptides, arginine-rich α-helical peptides that possess an unusual hydrophobic counterpart mainly composed of tyrosine residues. Guavanin 2 is characterized as a prototype peptide in terms of structure and activity. Nuclear magnetic resonance analysis indicates that the peptide adopts an α-helical structure in hydrophobic environments. Guavanin 2 is bactericidal at low concentrations, causing membrane disruption and triggering hyperpolarization. This computational approach for the exploration of natural products could be used to design effective peptide antibiotics.
Suggested Citation
William F. Porto & Luz Irazazabal & Eliane S. F. Alves & Suzana M. Ribeiro & Carolina O. Matos & Állan S. Pires & Isabel C. M. Fensterseifer & Vivian J. Miranda & Evan F. Haney & Vincent Humblot & Mar, 2018.
"In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design,"
Nature Communications, Nature, vol. 9(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03746-3
DOI: 10.1038/s41467-018-03746-3
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Paulina Szymczak & Marcin Możejko & Tomasz Grzegorzek & Radosław Jurczak & Marta Bauer & Damian Neubauer & Karol Sikora & Michał Michalski & Jacek Sroka & Piotr Setny & Wojciech Kamysz & Ewa Szczurek, 2023.
"Discovering highly potent antimicrobial peptides with deep generative model HydrAMP,"
Nature Communications, Nature, vol. 14(1), pages 1-23, December.
- Tingting Li & Xuanbai Ren & Xiaoli Luo & Zhuole Wang & Zhenlu Li & Xiaoyan Luo & Jun Shen & Yun Li & Dan Yuan & Ruth Nussinov & Xiangxiang Zeng & Junfeng Shi & Feixiong Cheng, 2024.
"A Foundation Model Identifies Broad-Spectrum Antimicrobial Peptides against Drug-Resistant Bacterial Infection,"
Nature Communications, Nature, vol. 15(1), pages 1-15, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03746-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.